Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesPreferred Shares IssuedSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Albemarle (ALB-PA) Cash from Financing Activities (2016 - 2025)

Albemarle's Cash from Financing Activities history spans 17 years, with the latest figure at -$533.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 473.87% year-over-year to -$533.0 million; the TTM value through Dec 2025 reached -$834.2 million, down 167.18%, while the annual FY2025 figure was -$834.2 million, 167.18% down from the prior year.
  • Cash from Financing Activities reached -$533.0 million in Q4 2025 per ALB-PA's latest filing, down from -$90.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.6 billion in Q1 2024 to a low of -$533.0 million in Q4 2025.
  • Average Cash from Financing Activities over 5 years is $84.7 million, with a median of -$77.9 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: surged 1891.77% in 2022, then crashed 473.87% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $308.6 million in 2021, then crashed by 196.99% to -$299.4 million in 2022, then soared by 232.62% to $397.0 million in 2023, then crashed by 123.4% to -$92.9 million in 2024, then plummeted by 473.87% to -$533.0 million in 2025.
  • Per Business Quant, the three most recent readings for ALB-PA's Cash from Financing Activities are -$533.0 million (Q4 2025), -$90.5 million (Q3 2025), and -$90.6 million (Q2 2025).